Program overview
Context
Indication: Ovarian Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: Genelux Corporation
Olvi-Vec is flagged as low signal because public records show operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Indication: Ovarian Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: Genelux Corporation
Registry: 0/5
Timeline: 0/5
Recruitment burden: 2/5
Results availability: 0/5
Program risk: 1/5
https://clinicaltrials.gov/study/NCT02759588
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT02759588 | Low Signal (COMPLETED) | None | Low Signal | rare_population_signal | strict_eligibility_signal |